Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow

Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow

Abstract Objective Coronary slow flow (CSF) is characterized by delayed opacification of distal epicardial coronary arteries without significant coronary stenosis. In addition, The changes of lipoprotein-associated phospholipase A2 (Lp-PLA2) as a significant predictive factor for CSF remain controve...

Full description

Bibliographic Details
Main Authors: Yao-dong Ding, Yu-qiang Pei, Rui Wang, Jia-xing Yang, Yin-xin Zhao, Xiao-li Liu, Hua Shen, Qian Ma, Shuo Zhang, Hai-long Ge
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Cardiovascular Disorders
Subjects:
Coronary slow flow
Lipoprotein-associated phospholipase A2
Coronary artery disease
Online Access:http://link.springer.com/article/10.1186/s12872-020-01463-8

Internet

http://link.springer.com/article/10.1186/s12872-020-01463-8

Similar Items